True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123?

Nuclear Medicine and Biology

Volumn 35, Issue 5, 2008, Pages 523-527

  Eckelman, William C ^a   Bonardi, Mauro ^b   Volkert, Wynn A ^c  

^a Molecular Tracer LLC   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c INFN LASA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORINE 18; INDIUM 111; IODINE 123; IODINE 125; IODINE 131; NITROGEN 13; OXYGEN 15; TECHNETIUM 99M; TRACER;

DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG UPTAKE; EDITORIAL; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY;

ALGORITHMS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IODINE RADIOISOTOPES; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS; SODIUM PERTECHNETATE TC 99M; SPECTROPHOTOMETRY, ULTRAVIOLET; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 45549097489     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.03.005     Document Type: Editorial

References (47)

1. Levi H. "George Hevesy and his concept of radioactive indicators-in retrospect". Eur J Nucl Med Mol Imaging 1 (1976) 3-10
2. Ehrlich P. On immunity, with special reference to cell-life (Croonian Lecture, Royal Society of London, 1990), reprinted in Collected Papers of Ehrlich P, vol 2, ed (1957), Pergamon Press, Himmelweit, New York, NY 178-195
3. Scheibe P.O. Identifiability analysis of second-order systems. Nucl Med Biol. 30 8 (2003) 827-832
4. Kilbourn M.R. Fluorine-18 labeling of radiopharmaceuticals. Prepared for the Committee on Nuclear and Radiochemistry, National Research Council (1990), National Academy Press, Washington (DC) 17-18
5. Coenen H.H., Dutschika K., Muller S.P., et al. N.C.A. Radiosynthesis of [123,124I]b-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET. Nucl Med Biol 22 (1995) 977-984
6. Boswell C.A., and Brechbiel M.W. Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. Nucl Med Biol 34 (2007) 757-778
7. http://www.IUPAC.org, Project of analytical chemistry division: terminology, quantities and units concerning production and applications of radionuclides in radiopharmaceutical and radioanalytical chemistry, Chair Mauro L. Bonardi.
8. Szajek L.P., Kao C.H.K., Kiesewetter D.O., Sassaman M.B., Lang L., Plascjak P., et al. Semi-remote production of Br-76 and preparation of high specific activity radiobrominated pharmaceuticals for PET studies. Radiochim Acta 92 (2004) 291-295
9. Laforest R., Rowland D.J., and Welch M.J. MicroPET imaging with non-conventional isotopes. Nuclear science symposium conference record. IEEE 3 (2001) 1572-1576
10. 99mTc generators. Appl Radiat Isot 63 (2005) 37-40
11. Boyd R.E. Technetium-99m generators the available options. Int J Appl Radiat lsot. 33 (1982) 801-809
12. Bonardi M.L., Birattari C., Groppi F., et al. Cyclotron production and quality control of "high specific activity" radionuclides in "no-carrier-added" form for radioanalytical applications in the life sciences. J Radioanal Nucl Chem 259 3 (2004) 415
13. Bonardi M.L., De Goeij J.J.M., and Radioanal J. How do we ascertain specific activities in no-carrier-added radionuclide preparations?. Nucl Chem 263 1 (2005) 87
14. De Goeij J.J.M., Bonardi M.L., and Radioanal J. How do we define the concepts specific activity, radioactive concentration, carrier, carrier-free and no-carrier-added?. Nucl Chem 263 1 (2005) 13
15. 99mTc-radiopharmaceuticals. Appl Radiat Isot 28 (1977) 83
16. Farrington K.J. High pressure liquid chromatography assay of technetium in solutions of sodium pertechnetate produced at the AAEC research establishment. Australian Atomic Energy Commission (1985) AAEC/E619, ISBN 064259818 5
17. 99mTc generator. Appl Radiat Isot 34 (1983) 901
18. Hill D.M., Barnes R.K., Wong H.K.Y., and Zawadzki A.W. The quantifi{ligature}cation of technetium in generator-derived pertechnetate using ICP-MS. Appl Radiat Isot 53 (2000) 415-419
19. 99Tc at low levels. Appl Radiat Isot. 65 (2007) 610-618
20. Eersels J.L.H., Travis M.J., and Herscheid J.D.M. Manufacturing I-123-labelled radiopharmaceuticals. Pitfalls and solutions. J Label Compd Radiopharm 48 (2005) 241-257
21. NIST Chemistry WebBook. NIST Standard Reference Database Number 69, June 2005 Release.
22. o] octreotide: does tumor or pancreas uptake correlate with the rate of internalization?. J Nucl Med 46 (2005) 1561-1569
23. 3. Cancer Res 63 (2003) 4082-4088
24. Greenland W.E., Howland K., Hardy J., et al. Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(Hynic-Boc)-lysine, a technetium binding amino acid: application to Tc-99m-labeled salmon calcitonin. J Med Chem 46 (2003) 1750-1757
25. Riddoch R.W., Schaffer P., and Valliant J.F. A solid-phase labeling strategy for the preparation of technetium and rhenium bifunctional chelate complexes and associated peptide conjugates. Bioconjug Chem 17 (2006) 226-235
26. Storch D., Schmitt J.S., Waldherr C., et al. Preclinical evaluation of somatostatin analogs bearing two macrocyclic chelators for high specific activity labeling with radiometals. Radiochim Acta 95 (2007) 359-369
27. Reubi J.C. Peptide receptors in molecular targets for cancer diagnostic and therapy. Endocr Rev 24 (2003) 389-427
28. Cone R.D., Lu D., Koppula S., et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 51 (1996) 287-317
29. 99mTc-labeled cyclic a-melanocyte stimulating hormone peptide analogues. Cancer Res 60 (2000) 5649-5658
30. Virgolini I., Raderer M., Kurtaran A., et al. Vasoactive intestinal peptide-receptor imaging for localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 331 (1994) 1116-1121
31. Schaffalitzky D.E., Muckadel O.B., Aggestrup S., and Stentoft P. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man. Scand J Gastroenterol 21 (1986) 498-502
32. Jansen J.B., Jebbink M.C., Douglas B.R., et al. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man. Eur J Clin Pharmacol 38 (1990) 367-370
33. Bertaccini G., Impicciatore M., Molina E., and Zappia L. Action of bombesin on human gastrointestinal tract - in vitro. Acta Biomed 44 3 (1973) 159-166
34. Hoffman T.J., Quinn T.P., and Volkert W.A. Radiometalled receptor-avid peptide conjugates for specific in vivo targeting of cancer cells. Nucl Med Biol 28 (2001) 527-539
35. 2; an in vitro/in vivo structure-activity relationships study where X = 0,3,5,8, and 11 carbon tethering modalities. Bioconjug Chem 14 (2003) 93-102
36. Van de Wiele C., Dumont F., VandenBroecke R., et al. Tc-99mRP527, a GRP analogue for visualization of GRP receptor expressing malignancies: a feasibility study. Eur J Nucl Med 11 (2000) 1694-1699
37. Van de Wiele C., Dumont F., Dierckx R.A., et al. Biodistribution and dosimetry of Tc-99m-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP-receptor-expressing malignancies. J Nucl Med 42 (2001) 1722-1727
38. Kuhl D.E., Koeppe R.A., Fessler J.A., Minoshima S., Ackermann R.J., Carey J.E., et al. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 35 3 (1994) 405-410
39. Ravert H.T., Bencherif B., Madar I., and Frost J.J. PET imaging of opioid receptors in pain: progress and new directions. Curr Pharm Des. 10 7 (2004) 759-768
40. Pimm M.V. Circulating antigen: bad or good for immunoscintigraphy?. Nucl Med Biol 22 (1995) 137-145
41. Kobayashi H., Sun B.F., Yoo T.M., et al. Circulating antigen on biodistribution of 1251 labeled AntiTac dsFv: preinjection of intact antibody versus clearance of antigen with avidin-biotin system. Nucl Med Biol 40 (1999) 1381-1391
42. de Jong M., Breeman W.A., Bernard B.F., et al. Tumor uptake of the radiolabeled somatostatin analog [DOTAo, Tyr3]octreotide is dependent upon peptide amount. Eur J Nucl Med 26 (1999) 693-698
43. 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J Nucl Med 2006:47:11--44--1152.
44. Breeman W.A., Kwekkeboom D.J., Kooij P.P., et al. Effect of dose and specific activity on tissue distribution of indium-111-pentreotide in rats. J Nucl Med 36 (1995) 625-627
45. Kung H.F., Kung M.P., Wey S.P., et al. Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT. Nucl Med Biol 34 (2007) 787-798
46. Hyllbrant B., Tyrefors N., Markides K.E., and Langstrom B. On the use of liquid chromatography with radio and ultraviolet absorbance detection coupled to mass spectrometry for improved sensitivity and selectivity in determination of specifi{ligature}c radioactivity of radiopharmaceuticals. J Pharm Biomed Anal 20 (1999) 493-501
47. Vuong B.K., Kiesewetter D.O., Lang L., Ma Y., Eckelman W.C., and Channing M.A. An automated one-step one-pot [(18)F]FCWAY synthesis: development and minimization of chemical impurities. Nucl Med Biol 34 4 (2007) 433-438